An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue
- 1 May 2000
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 182 (5) , 1173-1183
- https://doi.org/10.1067/mob.2000.95834
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Efficacy of oral beta-agonist maintenance therapy in preterm labor: A meta-analysisObstetrics & Gynecology, 1995
- Neonatal Complications after the Administration of Indomethacin for Preterm LaborNew England Journal of Medicine, 1993
- Uterine oxytocin gene expression: a novel framework for oxytocin actionRegulatory Peptides, 1993
- Treatment of Preterm Labor with the Beta-Adrenergic Agonist RitodrineNew England Journal of Medicine, 1992
- Oxytocin secretion and human parturition: Pulse frequency and duration increase during spontaneous labor in womenAmerican Journal of Obstetrics and Gynecology, 1991
- Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm laborAmerican Journal of Obstetrics and Gynecology, 1991
- Regulation of Intracellular Free Calcium in Human Myometrial Cells by Prostaglandin F2α: Comparison with Oxytocin*Journal of Clinical Endocrinology & Metabolism, 1990
- Follow-up of Prematurely Born InfantsClinical Obstetrics and Gynecology, 1988
- Beta‐mimetics in preterm labour: an overview of the randomized controlled trialsBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Cardiovascular complications associated with terbutaline treatment for preterm laborAmerican Journal of Obstetrics and Gynecology, 1981